UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience

Blood, 2013-12, Vol.122 (26), p.4279-4286

2013

Volltextzugriff (PDF)

Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non‐Hodgkin B‐cell lymphomas

European journal of haematology, 2020-05, Vol.104 (5), p.499-508

2020

Volltextzugriff (PDF)

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria

American journal of hematology, 2024-09, Vol.99 (9), p.1757-1767

2024

Volltextzugriff (PDF)

S183: PHASE III RANDOMIZED, MULTICENTER, OPEN‐LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR‐EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

HemaSphere, 2023-08, Vol.7 (S3), p.e45540d8-n/a

2023

Volltextzugriff (PDF)

Pixantrone beyond monotherapy: a review

Annals of hematology, 2019-09, Vol.98 (9), p.2025-2033

2019

Volltextzugriff (PDF)

Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

Leukemia & lymphoma, 2015-03, Vol.56 (3), p.656-662

2015

Volltextzugriff (PDF)

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL

HemaSphere, 2023-08, Vol.7 (S3), p.e813564b-n/a

2023

Volltextzugriff (PDF)

Rituximab and Specific Therapy for Patients with Burkitt's Leukemia and Lymphoma. Results of the BURKIMAB14 Trial from the Spanish Pethema and Geltamo Groups in 80 Patients

Blood, 2019-11, Vol.134 (Supplement_1), p.2584-2584

2019

Volltextzugriff (PDF)

MCL-113: IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/Refractory Mantle-Cell Lymphoma (MCL) Treated with Ibrutinib in Routine Clinical Practice

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S258-S259

2020

Volltextzugriff (PDF)

Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis and Study of the Impact of Hematopoietic Graft Source

Biology of blood and marrow transplantation, 2010-07, Vol.16 (7), p.957-966

2010

Volltextzugriff (PDF)

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

Blood, 2018-11, Vol.132 (Supplement 1), p.2936-2936

2018

Volltextzugriff (PDF)

Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients

Antiviral therapy, 2011-01, Vol.16 (7), p.951-957

2011

Volltextzugriff (PDF)

Preben: Pixantrone, Rituximab, Etoposide and Bendamustine, Spanish Experience in Diffuse Large B-Cell Lymphoma Treatment

Blood, 2017-12, Vol.130, p.5235-5235

2017

Volltextzugriff (PDF)

Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain

Biology of blood and marrow transplantation, 2020-08, Vol.26 (8), p.1534-1542

2020

Volltextzugriff (PDF)

Graft-Failure After Allogeneic Stem Cell Transplantation. Outcome and Prognostic Factors in 80 Patients

Blood, 2011-11, Vol.118 (21), p.1936-1936

2011

Volltextzugriff (PDF)

Graft Versus Host Disease after Granulocyte Infusion

Blood, 2006-11, Vol.108 (11), p.5266-5266

2006

Volltextzugriff (PDF)

Double Syngeneic Transplantation in Plasma Cell Leukaemia

Blood, 2006-11, Vol.108 (11), p.5347-5347

2006

Volltextzugriff (PDF)

Re-Treatment with Rituximab Plus Chemotherapy in Patients with Aggressive Lymphoma Treated Previously with CHOP or CHOP-Like Combinations Plus Rituximab

Blood, 2006-11, Vol.108 (11), p.4707-4707

2006

Volltextzugriff (PDF)

Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors

Biology of blood and marrow transplantation, 2012, Vol.18 (1), p.100-105

2012

Volltextzugriff (PDF)

Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

Leukemia & Lymphoma, 2015, Vol.56 (3), p.656-662

2015

Volltextzugriff (PDF)

Differences in Physiological Responses During Wheelchair Basketball Matches According to Playing Time and Competition

Research quarterly for exercise and sport, 2018-10, Vol.89 (4), p.474-481

2018

Volltextzugriff (PDF)

Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer

Cancers, 2018-09, Vol.10 (9), p.300

2018

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Hematology
(10)
Humans
(10)
Adult
(7)
Male
(7)
Middle Aged
(7)
Adolescent
(6)
Female
(6)
Aged
(5)
Young Adult
(5)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(4)
Oncology
(4)
Retrospective Studies
(4)
Treatment Outcome
(4)
Child
(3)
Immunology
(3)
Patients
(3)
Survival Rate
(3)
Transplantation
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(9)
Biology Of Blood And Marrow Transplantation
(3)
Hemasphere
(2)
Retos
(2)
American Journal Of Hematology
(1)
Annals Of Hematology
(1)
Antiviral Therapy
(1)
Aster
(1)
Cancers
(1)
Clinical Lymphoma, Myeloma And Leukemia
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience

Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non‐Hodgkin B‐cell lymphomas

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria

Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

S183: PHASE III RANDOMIZED, MULTICENTER, OPEN‐LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR‐EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

Pixantrone beyond monotherapy: a review

Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL

Rituximab and Specific Therapy for Patients with Burkitt's Leukemia and Lymphoma. Results of the BURKIMAB14 Trial from the Spanish Pethema and Geltamo Groups in 80 Patients

MCL-113: IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/Refractory Mantle-Cell Lymphoma (MCL) Treated with Ibrutinib in Routine Clinical Practice

Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis and Study of the Impact of Hematopoietic Graft Source

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients

Preben: Pixantrone, Rituximab, Etoposide and Bendamustine, Spanish Experience in Diffuse Large B-Cell Lymphoma Treatment

Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain

Graft-Failure After Allogeneic Stem Cell Transplantation. Outcome and Prognostic Factors in 80 Patients

Graft Versus Host Disease after Granulocyte Infusion

Double Syngeneic Transplantation in Plasma Cell Leukaemia

Re-Treatment with Rituximab Plus Chemotherapy in Patients with Aggressive Lymphoma Treated Previously with CHOP or CHOP-Like Combinations Plus Rituximab

Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source

Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors

Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

Differences in Physiological Responses During Wheelchair Basketball Matches According to Playing Time and Competition

Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer

Suchergebnisse filtern